Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +35.77%
#2 Siren Siren +30.45%
#3 Purr Purr +29.34%
#4 OriginTrail OriginTrail +23.32%
#5 UnifAI Network UnifAI Network +16.08%
#6 Wrapped XPL Wrapped XPL +14.62%
#7 龙虾 (Lobster) 龙虾 (Lobster) +14.51%
#8 Pendle Pendle +14.37%
#9 ApeX ApeX +14.28%
#10 Morpho Morpho +13.97%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Rang in aandelen #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Aandeelprijs
$2.10
Laatst gesynchroniseerd: 2026-08-21
Marktkapitalisatie
$104.43M
Verandering (1 dag)
-2.10%
Verandering (1 jaar)
-
Land
US
Handel Polaryx Therapeutics, Inc. Common Stock (PLYX)

Categorie

Healthcare
P/S-ratio voor Polaryx Therapeutics, Inc. Common Stock (PLYX)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Polaryx Therapeutics, Inc. Common Stock is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Polaryx Therapeutics, Inc. Common Stock van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH